Quick answers
- What is Gilotrif?
- Gilotrif is a brand name of Afatinib, a prescription medicine. The FDA NDC Directory lists 3 Gilotrif products in 3 strengths and forms.
- Who makes Gilotrif?
- Boehringer Ingelheim holds the FDA application for Gilotrif (NDA201292, approved July 12, 2013).
- Is there a generic or store brand of Gilotrif?
- Other products of Afatinib are listed with the FDA, but none in exactly the same strength and form as a Gilotrif product.
- Has Gilotrif been recalled?
- No recall linked to Gilotrif products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Gilotrif is
Each Gilotrif product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Afatinib · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| afatinib 20 mg tablet, film coated (oral) | Gilotrif | None listed | DailyMed |
| afatinib 30 mg tablet, film coated (oral) | Gilotrif | None listed | DailyMed |
| afatinib 40 mg tablet, film coated (oral) | Gilotrif | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Afatinib →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA201292 | Boehringer Ingelheim | July 12, 2013 | 3 |
Companies that list Gilotrif
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Gilotrif products.
Recalls
No recall linked to Gilotrif products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.